Sullivan & Worcester advised Wearable Devices Ltd. on the offering. Wearable Devices Ltd (Nasdaq: WLDS, WLDSW) completed its $2.5 million “best efforts” public offering of ordinary...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester was placement agent’s counsel for A.G.P./Alliance Global Partners and Maxim Group LLC in connection with the offering. SELLAS Life Sciences Group, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler advised Sonnet BioTherapeutics, while Sullivan & Worcester advised Chardan Capital Markets on the offering. Sonnet BioTherapeutics Holdings, Inc. (Nasdaq: SONN), a clinical-stage company developing...
You must be a Standard 1 Year member to access this content.
Dorsey & Whitney advised Shuttle Pharmaceuticals, while Sullivan & Worcester advised A.G.P./Alliance Global Partners in the offering. Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) announced the pricing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised BioCardia, while Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. BioCardia, Inc. (Nasdaq: BCDA) completed its $7.2 million...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. Gorilla Technology Group, Inc. (Nasdaq: GRRR) executed a $12 million offering of ordinary shares and warrants....
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. Soligenix, Inc. (Nasdaq: SNGX) $4.75 million public offering of common stock and warrants, consisting of 11,875,000...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester represented the underwriter ThinkEquity LLC in the offering. Beamr Imaging Ltd. executed its $13.8 million public offering of ordinary shares. The underwriter’s option...
You must be a Standard 1 Year member to access this content.
ArentFox Schiff advised CNS Pharmaceuticals, while Sullivan & Worcester advised the placement agents on the offering. CNS Pharmaceuticals, Inc., a biopharmaceutical company specializing in the development...
You must be a Standard 1 Year member to access this content.
